FORA Capital LLC Raises Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

FORA Capital LLC boosted its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 6.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,618 shares of the company’s stock after acquiring an additional 992 shares during the quarter. FORA Capital LLC’s holdings in Ryan Specialty were worth $1,170,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Hollencrest Capital Management purchased a new stake in Ryan Specialty during the 3rd quarter valued at about $25,000. Assetmark Inc. purchased a new stake in Ryan Specialty in the 3rd quarter worth approximately $34,000. GAMMA Investing LLC lifted its holdings in Ryan Specialty by 96.4% in the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock worth $35,000 after buying an additional 297 shares during the period. Crewe Advisors LLC purchased a new stake in Ryan Specialty in the 2nd quarter worth approximately $39,000. Finally, Signaturefd LLC lifted its holdings in Ryan Specialty by 12.3% in the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after buying an additional 148 shares during the period. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on RYAN shares. The Goldman Sachs Group increased their price objective on Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a report on Wednesday, October 9th. Barclays increased their price objective on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. BMO Capital Markets upgraded Ryan Specialty from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $65.00 to $75.00 in a report on Tuesday, September 24th. JPMorgan Chase & Co. increased their price objective on Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a report on Friday, August 2nd. Finally, Wells Fargo & Company increased their target price on Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 10th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, Ryan Specialty has a consensus rating of “Hold” and an average target price of $71.67.

Insiders Place Their Bets

In other news, EVP Mark Stephen Katz sold 14,790 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $71.39, for a total value of $1,055,858.10. Following the transaction, the executive vice president now directly owns 12,386 shares in the company, valued at $884,236.54. This trade represents a 54.42 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director David P. Bolger sold 7,055 shares of the firm’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total value of $500,058.40. Following the completion of the transaction, the director now owns 78,149 shares in the company, valued at approximately $5,539,201.12. This trade represents a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company’s stock.

Ryan Specialty Stock Up 0.0 %

RYAN stock opened at $75.10 on Thursday. Ryan Specialty Holdings, Inc. has a twelve month low of $41.49 and a twelve month high of $75.86. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a market cap of $19.66 billion, a PE ratio of 97.53, a price-to-earnings-growth ratio of 1.69 and a beta of 0.62. The business has a 50 day moving average of $69.50 and a 200 day moving average of $62.95.

Ryan Specialty (NYSE:RYAN) last posted its earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting analysts’ consensus estimates of $0.41. The business had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The company’s quarterly revenue was up 20.5% compared to the same quarter last year. During the same quarter last year, the company earned $0.32 EPS. On average, research analysts forecast that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were issued a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.59%. The ex-dividend date was Tuesday, November 12th. Ryan Specialty’s payout ratio is 57.14%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.